Bioterrorism and disaster preparedness explored in special issue of Medical Decis... ( Los Angeles London New Delhi Singapo...)

Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making

Date:9/21/2009

Los Angeles, London, New Delhi, Singapore and Washington DC (July 27, 2009) According to a study in a special issue of Medical Decision Making, a large-scale, covert anthrax attack on a large city would overwhelm hospital resources even with an extremely effective public health response, primarily because of expected delays in detecting the attack and initiating a response to it.

The article "Predicting Hospital Surge after a Large-Scale Anthrax Attack: A Model-Based Analysis of CDC's Cities Readiness Initiative Prophylaxis Recommendations," examines one of the CDC's principal bioterrorism-response programs, the Cities Readiness Initiative (CRI), a program that recommends the medical countermeasures necessary to minimize the hospital surge resulting from anthrax-related illness and response in the first two days after a major bioterrorism attack.

The researchers found that a CRI-compliant prophylaxis campaign starting two days after exposure would protect as many as 86% of exposed individuals from illness. However, each additional day needed to complete the campaign would result in as much as 3% more hospitalizations in the exposed population. Unsustainable levels of hospitalizations would result from delays in detecting and initiating response to large-scale, covert aerosol anthrax releases in a major city, even with highly effective mass prophylaxis campaigns.

The article, written by Nathaniel Hupert, incorporates some of the latest type of modeling techniques scientists use in the disaster preparedness.field. Such models have become increasingly important to public health officials and hospital administrators. To improve the consistency and quality of these models, the Society for Medical Decision Making convened experts to recommend best practices for modeling the public health response to a terror attack. Their article, also published in the current issue of Medical Decision Making, is entitled

<
'/>"/>

Contact: Jim Gilden
media.inquiries@sagepub.com
SAGE Publications
Source:Eurekalert

0

GOOD

Page: 1 2
Related biology technology :

1. Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making
2. Thomson Reuters Examines Highly Cited Research in Bioterrorism
3. JMAR Technologies Raises Awareness of BioSentry -- A High Tech Counter to Bioterrorism
4. Avalanche photodiodes target bioterrorism agents
5. Avalanche photodiodes target bioterrorism agents
6. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
7. New study examines effects of Graniteville, S.C., chlorine gas disaster
8. Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas
9. Millstone Medical Outsourcing Relocates Memphis Distribution Center Within 72 Hours of Tornado Disaster
10. Triage study challenges notions of emergency medical response to disaster
11. ORNL resilience plan to help Tennessee, Mississippi and South Carolina communities beat disaster

Post Your Comments:

(Date:12/15/2009)... Reportlinker.com announces that a new ... catalogue: ,, The Future of ... 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The author ... of Orphan Diseases Therapeutics - Market Forecasts ...

(Date:12/15/2009)... Mosaic Company (NYSE: MOS ) plans to ... and financial tables on Tuesday, January 5, 2010, after ... Exchange. Results will be available on Mosaic,s website ... a conference call with presentation slides on Wednesday, January ... will begin at 11:00 a.m. Eastern Standard Time (10:00 ...

(Date:12/15/2009)... LONDON, Dec. 15 Thomson ... Pharma ® has become the first drug pipeline ... and outcome information. This highly anticipated new content ... this month. ,, Thomson Pharma ... from registries, publications, press releases, conferences, and other ...

(Date:12/14/2009)... Calif., Dec. 14 Vermillion, Inc. ... today announced William C. Wallen, Ph.D. Chief ... Development for IDEXX Laboratories, will be joining ... Vermillion,s bankruptcy plan. ,, "Bill brings ... experience in diagnostics and biotechnology," said Gail ...

[0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call [0] Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials [0] Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors

... HOUSTON, July 16 US Oncology Holdings, Inc. ... 2008 second quarter,financial results on Thursday, August 7, ... has been scheduled at 11:00,a.m., EDT, for the ... In this call, representatives of US Oncology,s management,team ...

... Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) today announced ... results on Wednesday, July 23,2008, after the market closes. ... at 2:00 p.m. PT, which will be open to ... the company will review,the financial results and discuss other ...

... July 16 The Brazilian Sugarcane,Industry Association (UNICA) ... Policies" as another major report that highlights the,benefits ... reduction and,urges governments to level the playing field ... weeks, reports by diverse organizations such as FAO, ...

Other Biology Technology:Sangamo BioSciences Announces Second Quarter Conference Call and Webcast 2 Sangamo BioSciences Announces Second Quarter Conference Call and Webcast 3 Brazilian Sugarcane Industry: OECD Report Confirms Overall Benefits of Brazilian Sugarcane Ethanol 2 Brazilian Sugarcane Industry: OECD Report Confirms Overall Benefits of Brazilian Sugarcane Ethanol 3

US Oncology to Report 2008 Second Quarter Earnings Results Sangamo BioSciences Announces Second Quarter Conference Call and Webcast Brazilian Sugarcane Industry: OECD Report Confirms Overall Benefits of Brazilian Sugarcane Ethanol

(Date:12/16/2009)... Dec. 8, 2009 National Instruments ... industrial measurement and control, and DENSO Robotics, ... using robotics technology, today announced their collaboration ... with DENSO robotic arms. The collaboration increases ... and flexible manufacturing applications. In today,s trend ...

(Date:12/15/2009)... LONDON, Dec. 15 The 2009 ... Innovation Award is presented to Sagem Securite ... Control systems. The award recognises the company,s ... continuous stewardship in offering novel, value-added products ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, "Sagem Securite has ...

(Date:12/15/2009)... environmental impacts, social dynamics, and production levels are ... of an agroecosystem. Positive or negative, these factors ... social groups to continuously adapt farming and food ... learning theory suggests that knowledge is gained as ... are especially valuable for environmental and agricultural educators ...

Breaking Biology News(10 mins):National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2 National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3 National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4 National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5 Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2 Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3 Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4 Experiential learning teaches change and adaptation 2 Arena Pharmaceuticals to Host Conference Call and Webcast on Friday September 18 2009 to Discuss Results from the BLOSSOM Phase 3 Trial of Lorcaser 5016 1 Arena Pharmaceuticals to Host Conference Call and Webcast on Friday September 18 2009 to Discuss Results from the BLOSSOM Phase 3 Trial of Lorcaser 5016 2 Arena Pharmaceuticals to Host Conference Call and Webcast on Friday September 18 2009 to Discuss Results from the BLOSSOM Phase 3 Trial of Lorcaser 5016 3 Study Links Epilepsy to Brain Protein 57562 1 Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 1 Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 2 Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 3

[0] National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics [0] Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems [0] Experiential learning teaches change and adaptation

... Columbia University's Mailman School of Public Health, the Centers ... Research Center have discovered a key mechanism by which ... identification of an amino acid sequence in Filoviruses that ... described in the December 2006 issue of The FASEB ...

... cheap, quick and copyright-respecting way to turn existing print ... in an experimental beta version for free download, is ... the most popular computer operating systems. , "Brain ... says Gully A.P.C. Burns, a specialist in neuroinformatics who ...

... levels of the virus associated with cervical cancer can ... according to a study published in the November 2006 ... Anthony Gunnell, a medical biostatistician and epidemiologist and colleagues ... exams of women with non-invasive cervical cancer in situ ...

Other Biology News:Researchers discover key mechanism by which lethal viruses Ebola and Marburg cause disease 2 Beyond the book: Software automates access to brain atlases 2 Beyond the book: Software automates access to brain atlases 3 High HPV concentrations combined with smoking significantly raise risks of cervical cancer 2 High HPV concentrations combined with smoking significantly raise risks of cervical cancer 3

Researchers discover key mechanism by which lethal viruses Ebola and Marburg cause disease Beyond the book: Software automates access to brain atlases High HPV concentrations combined with smoking significantly raise risks of cervical cancer

... NOBLE BSA-Free Stabilizer is a bovine ... It is an aqueous solution ... a MOPS buffer (3-(N-Morpholino) propanesulfonic acid), ... a combination of 0.02% methylisothiazolone and ...

These 96-well 0.2 ml thin-wall PCR plate caps are caps that are used to seal 96-well, 0.2 ml thin-wall PCR plates. Supplied as 300 caps....

... software with the DeCypher Engine accelerator cards to ... perform searches like these from your desktop: ... under 6 days Align BAC-sized queries ... HMM analysis to compare 100,000 sequences to PFAM ...

Mouse monoclonal antibody to FMN2 - formin 2...

Biology Products:

StabilZyme NOBLE BSA-Free Stabilizer from SurModics, Inc.96-well 0.2 ml PCR Plate Caps, 300 from Bio-Rad DeCypher Biocomputing Solutions from TimeLogic, a Brand of Active Motif, Inc.Mouse Anti-Human FMN2 Monoclonal Antibody, Unconjugated, Clone 4B8 from Novus Biologicals

Bioterrorism and disaster preparedness explored in special issue of Medical Decis...( Los Angeles London New Delhi Singapo...)